AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FDA warns on anemia drugs after test deaths.
Byline: Christopher Rowland
Mar. 10--Responding to a spate of deaths in clinical trials, the Food and Drug Administration yesterday issued its most severe warning possible for drugs widely used to treat anemia in kidney disease patients and cancer patients undergoing chemotherapy.
The "black box" warnings placed on the prescribing label for Amgen Inc.'s Epogen and Aranesp and Johnson & Johnson's Procrit are expected to result in more cautious dosing by doctors.
Use of the drugs has escalated as physicians have sought to improve the quality of life of anemic patients by using them to stimulate creation of energy-boosting red blood cells. Marketing by manufacturers has reinforced the trend. But the FDA said yesterday that recent clinical trials have shown treatment beyond recommended limits increases the…
- Cytosol Announces FDA Approval of Red Blood Cell Rejuvenation Product
- Press release article from: PR Newswire February 27, 1997 700+ words
...Inc. announces FDA approval for the use of their red blood cell rejuvenation...biochemically modify stored red blood cells back to their...over 75% of donated red blood cells are stored in...corporation, is a FDA licensed drug and...
- Haemonetics receives first FDA market approval for automated red blood cell...
- Press release article from: Business Wire October 25, 1995 700+ words
...collection of one unit of red blood cells and two units of...first of several automated red blood cell (RBC) collection...continue to work with the FDA to obtain 510(k) premarket...Company's U.S. automated red blood cell collection business...
- HemaSure Receives U.S. FDA Clearance for Its r\LS Red Blood Cell Filtration...
- Press release article from: PR Newswire June 1, 1999 700+ words
...today announced that its r\LS Red Blood Cell Filtration System has received...S. Food and Drug Administration (FDA). HemaSure intends to launch the...HemaSure on developing and delivering a red blood cell filter that meets our customers...
- ThermoGenesis' Medical Device Receives FDA Clearance for Thawing of Frozen Red...
- Press release article from: PR Newswire July 9, 2003 700+ words
...CORP. announced today that the Food and Drug Administration (FDA) cleared the ThermoGenesis Medical Thawer for use with frozen glycerolized red blood cells (RBC). Originally FDA cleared to thaw frozen blood plasma, these sophisticated heat...
- Haemonetics receives FDA market clearance for 2 unit automated red blood cell...
- Press release article from: Business Wire April 24, 1996 700+ words
...radically change the way red blood cells are collected in this country. FDA's 510(k) premarketing...collection of two units of red blood cells from autologous donors. At FDA's request, Haemonetics...collection of 2 units of red blood cells from normal...data requested ...
- FDA concurs with Vitex pivotal phase III Inactine red blood cell program.
- Newspaper article from: Blood Weekly August 8, 2002 700+ words
...Administration (FDA) to initiate its...pathogen reduction red blood cell system. The...patients who require red blood cell transfusion...stated, "The FDA agreement to proceed...consistent with licensed red blood cells." Barr continued...
- Cerus and Baxter Receive FDA Concurrence to Begin Phase III INTERCEPT Red Blood...
- Press release article from: Business Wire February 21, 2002 700+ words
...pivotal Phase III trial for the INTERCEPT Red Blood Cell System. This trial will evaluate INTERCEPT red blood cell use for chronic transfusion support...which is already underway. The INTERCEPT Red Blood Cell System is a pathogen inactivation...
- Red blood cell/CD4 therapy topic of meeting with FDA. (Food and Drug...
- Newspaper article from: AIDS Weekly February 14, 1994 700+ words
...Food and Drug Administration (FDA) regarding the company's development of a red blood cell/CD4 therapy (RBC...meeting, was to present to the FDA certain scientific concepts...complete and submit to the FDA in upcoming weeks. Further...
- FDA Concurs with Vitex Pivotal Phase III Inactine(TM) Red Blood Cell Program;...
- Press release article from: PR Newswire July 1, 2002 700+ words
...Administration (FDA) to initiate its...pathogen reduction red blood cell system. The...patients who require red blood cell transfusion...stated, "The FDA agreement to proceed...consistent with licensed red blood cells." Mr. John...
- Cerus Receives FDA Concurrence to Expand Inclusion Criteria for Phase III...
- Press release article from: Business Wire March 31, 2003 700+ words
...III trial for INTERCEPT Red Blood Cells for chronic transfusion...chronic trial recruitment to red blood cell exchange patients...reached concurrence with the FDA to revise the "Informed...50 patients who require red blood cell transfusion support...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
